Clinical trials for

Bradyarrhythmia

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing / Large-scale testing

Sāhīwāl, Punjab Province, PakistanCheck eligibility →

RecruitingObservational

Sylmar, California, United StatesCheck eligibility →

RecruitingInterventional

Coimbra, Portugal +2 moreCheck eligibility →

RecruitingObservational

Innsbruck, Tyrol, AustriaCheck eligibility →

RecruitingInterventional

Radom, Masovian Voivodeship, Poland +1 moreCheck eligibility →

RecruitingObservational

Bron, France +4 moreCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Sahiwal, Punjab Province, PakistanCheck eligibility →

RecruitingLarge-scale testing

Milan, ItalyCheck eligibility →

RecruitingInterventional

Cambridge, United Kingdom +4 moreCheck eligibility →

RecruitingObservational

London, UK, United Kingdom +1 moreCheck eligibility →

RecruitingInterventional

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingInterventional

New Delhi, National Capital Territory of Delhi, India +1 moreCheck eligibility →

RecruitingObservational

Düsseldorf, GermanyCheck eligibility →

RecruitingInterventional

Saint Petersburg, RussiaCheck eligibility →

RecruitingObservational

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Besançon, France, France +3 moreCheck eligibility →

RecruitingPost-approval study

Bern, SwitzerlandCheck eligibility →

RecruitingInterventional

Vigo, SpainCheck eligibility →

RecruitingInterventional

Scottsdale, Arizona, United States +4 moreCheck eligibility →

RecruitingObservational

Bruges, Belgium +4 moreCheck eligibility →

AI-generated · Refreshed daily · Not medical advice.

RecruitingSafety & dosing / Large-scale testing

Sāhīwāl, Punjab Province, PakistanCheck eligibility →

RecruitingObservational

Sylmar, California, United StatesCheck eligibility →

RecruitingInterventional

Coimbra, Portugal +2 moreCheck eligibility →

RecruitingObservational

Innsbruck, Tyrol, AustriaCheck eligibility →

RecruitingInterventional

Radom, Masovian Voivodeship, Poland +1 moreCheck eligibility →

RecruitingObservational

Bron, France +4 moreCheck eligibility →

RecruitingSafety & dosing / Large-scale testing

Sahiwal, Punjab Province, PakistanCheck eligibility →

RecruitingLarge-scale testing

Milan, ItalyCheck eligibility →

RecruitingInterventional

Cambridge, United Kingdom +4 moreCheck eligibility →

RecruitingObservational

London, UK, United Kingdom +1 moreCheck eligibility →

RecruitingInterventional

Shanghai, Shanghai Municipality, ChinaCheck eligibility →

RecruitingInterventional

New Delhi, National Capital Territory of Delhi, India +1 moreCheck eligibility →

RecruitingObservational

Düsseldorf, GermanyCheck eligibility →

RecruitingInterventional

Saint Petersburg, RussiaCheck eligibility →

RecruitingObservational

Birmingham, Alabama, United States +4 moreCheck eligibility →

RecruitingInterventional

Besançon, France, France +3 moreCheck eligibility →

RecruitingPost-approval study

Bern, SwitzerlandCheck eligibility →

RecruitingInterventional

Vigo, SpainCheck eligibility →

RecruitingInterventional

Scottsdale, Arizona, United States +4 moreCheck eligibility →

RecruitingObservational

Bruges, Belgium +4 moreCheck eligibility →

51 trials · Recruiting

51

Trials actively recruiting patients for Bradyarrhythmia

Trial status

Phase

Location